1 active not recruiting, 1 not yet recruiting, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow gallium maltolate: new trials by email Literature Review of gallium maltolate trials Research Report on gallium maltolate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor Gallium maltolate - High Grade Gliomas, Atypical Teratoid Rhabdoid Tumors (ATRT) | Phase 1 | Not yet recruiting | Sarah Rumler | 15 | 2026-05-15 | 2026-01-09 |
| Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma Gallium maltolate (500 mg), Gallium maltolate (1,000 mg), Gallium maltolate (1,500 mg) - Glioblastoma | Phase 1 | Active not recruiting | Medical College of Wisconsin | 26 | 2022-11-11 | 2025-11-03 |
| Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies Gallium maltolate - Prostatic Neoplasms, Multiple Myeloma | Phase 1 / Phase 2 | Terminated | Titan Pharmaceuticals | 2001-06-01 | 2011-01-28 |
Brain Neoplasms (1) · Diffuse Intrinsic Pontine Glioma (1) · Glioblastoma (1) · Glioma (1) · Lymphoma (1) · Multiple Myeloma (1) · Prostatic Neoplasms (1) · Recurrence (1) · Rhabdoid Tumor (1) · Urinary Bladder Neoplasms (1)
Medical College of Wisconsin (1) · Sarah Rumler (1) · Titan Pharmaceuticals (1)
United States (2)